BIG
RPRX icon

Brooklyn Investment Group’s Royalty Pharma RPRX Stock Holding History

Brooklyn Investment Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$368K Buy
7,675
+2,002
+35% +$87.7K 0.01% 1255
2025
Q4 		$222K Buy
+5,673
New +$216K 0.01% 1287
2025
Q3 		– Sell
-2,341
Closed -$84.3K – 2256
2025
Q2 		$84.3K Buy
2,341
+1,183
+102% +$39.2K 0.01% 1037
2025
Q1 		$36K Buy
1,158
+195
+20% +$6.18K 0.01% 921
2024
Q4 		$24.5K Buy
963
+876
+1,007% +$23.2K 0.01% 701
2024
Q3 		$2.46K Buy
+87
New +$2.41K ﹤0.01% 913

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Brooklyn Investment Group's RPRX Position: Q1 2026 in Review

Brooklyn Investment Group increased its Royalty Pharma (RPRX) stake by 35% in Q1 2026, buying an estimated $87.7K and bringing the position to 7,675 shares worth $368K. The position accounts for 0.01% of the portfolio, ranked #1255.

Brooklyn Investment Group first reported a position in RPRX in Q3 2024 and has held it in 6 quarters since. 592 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Brooklyn Investment Group held 7,675 shares of Royalty Pharma worth $368K as of Q1 2026.
  • Brooklyn Investment Group bought 2,002 Royalty Pharma shares in Q1 2026, an estimated $87.7K.
  • Royalty Pharma made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1255 holding.
  • Brooklyn Investment Group first reported a position in Royalty Pharma in Q3 2024 and has held it in 6 quarters since.
  • 592 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.